GGrantIndex
Sort

172,184 grants matching inflammation

Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis

$857,294
William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2016 · HL

The impact of intravenous heroin use on immune activation in treated HIV

$857,236
Grace A McComsey · Case Western Reserve University · R01 · FY2021 · DA

Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients

$857,225
Joren C Madsen · Massachusetts General Hospital · U01 · FY2011 · AI

Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)

$857,217
Michael John McGeachie · Brigham And Women'S Hospital · R01 · FY2021 · HL

Nikon Multiphoton (MP) Imaging System

$857,209
James E Cassat · Vanderbilt University Medical Center · S10 · FY2023 · OD

AsthmaNet: Phenotypic Influences on Asthma Treatments

$857,131
Sally E Wenzel · University Of Pittsburgh At Pittsburgh · U10 · FY2011 · HL

Immunobiology of Lung Injury and Fibrosis

$857,103
Bethany B. Moore · University Of Michigan At Ann Arbor · R35 · FY2023 · HL

TAM Receptors and Virus Infection

$857,077
Greg E Lemke · Salk Institute For Biological Studies · R01 · FY2017 · AI

The Epidemiology of Bone Strength and Muscle Composition After Hip Fracture in Me

$856,953
Jay Steven Magaziner · University Of Maryland Baltimore · R01 · FY2010 · AG

Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients

$856,882
Joren C Madsen · Massachusetts General Hospital · U01 · FY2012 · AI

Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients

$856,882
Joren C Madsen · Massachusetts General Hospital · U01 · FY2014 · AI

Developing a new drug for treating myocardial ischemia/reperfusion injury

$856,873
Randal A Skidgel · Dupage Medical Technology, Inc. · R44 · FY2021 · HL

Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity

$856,837
Chiadi E Ndumele · Johns Hopkins University · R01 · FY2019 · HL

The impact of intravenous heroin use on immune activation in treated HIV

$856,800
Grace A McComsey · Case Western Reserve University · R01 · FY2020 · DA

Defining the Role of ANKEF1 in Ciliary Function and Host Defense Against Influenza Virus Infection

$856,791
Lisa Miorin · Icahn School Of Medicine At Mount Sinai · R56 · FY2025 · AI

Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis

$856,782
Chad Allen Koplinski · Xlock Biosciences, Llc · R44 · FY2020 · AR

Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD

$856,728
Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2023 · HL

Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD

$856,728
Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2025 · HL

Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities

$856,702
Charles T Roberts · Oregon Health & Science University · R01 · FY2019 · DK

EPITHELIAL FUNCTION AND DYSFUNCTION IN CHRONIC SINUSITIS

$856,607
Johns Hopkins University · P01 · FY2000 · AI

Microbiome and AD/ADRD Risk in SOL

$856,580
Natalia Palacios · University Of Massachusetts Lowell · R01 · FY2025 · AG

Crystallographic studies of macromolecular structures

$856,445
Lars Pedersen · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES

Activation of probiotic bifidobacteria by milk glyans

$856,424
David Andrew Mills · University Of California At Davis · R01 · FY2014 · AT

Impact of Stretching on Tumor growth and Metastasis

$856,418
Helene Langevin · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE

Preventing GVHD by inhibition of alloantigen presentation in the gut

$856,395
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2023 · HL